ARIAD Pharma (ARIA) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Price: $25.09 -1.72%
Financial Fact:
Total operating expenses: 71.01M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Total operating expenses: 71.01M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
ARIAD Pharma (NASDAQ: ARIA) reported Q3 EPS of ($0.27), $0.03 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $14.7 million versus the consensus estimate of $16.5 million.
For earnings history and earnings-related data on ARIAD Pharma (ARIA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- AXIL Brands (AXIL) Tops Q4 EPS by 4c
- Iridex Corp (IRIX) Misses Q2 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
